Pulmonary Invasive Aspergillosis clinical trials at UCSF

• Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

  open to eligible people ages up to 21 years

  This study will establish a non-invasive diagnostic approach and evaluate clinical outcomes for children at high-risk for pulmonary invasive mold infection (PIMI).

  San Francisco, California and other locations

Last updated: December 23, 2020